{"id":56241,"date":"2023-04-26T15:04:34","date_gmt":"2023-04-26T13:04:34","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/"},"modified":"2023-04-26T15:04:34","modified_gmt":"2023-04-26T13:04:34","slug":"american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/","title":{"rendered":"American Vascular Associates Announces Growth Recapitalization by Petra Capital and Canopy Capital"},"content":{"rendered":"
\n

TAMPA BAY, Fla.–(BUSINESS WIRE)–Officials with American Vascular Associates, LLC (AVA)<\/a>, a nationally recognized network of outpatient vascular and endovascular centers based in Palm Harbor, Fla., announced today the company\u2019s completion of a growth recapitalization by two leading investment firms, Petra Capital Partners<\/a> (Nashville, Tenn.) and Canopy Capital Partners<\/a> (Tampa, Fla.). This transaction will allow for AVA\u2019s accelerated growth and additional physician partnerships as the demand for office-based labs and ambulatory surgery centers continues to grow.<\/p>\n

<\/a><\/p>\n

\n\u201cAfter an exhaustive national search for the right partner, we are thrilled that both Petra Capital and Canopy Capital made the decision to take this journey with us,\u201d said Jan Dees, Founder and Chief Executive Officer of American Vascular Associates. \u201cTogether, with our new financial partners and the existing AVA team, who will remain shareholders in AVA, we will be well-positioned to positively impact our growth trajectory by providing an outpatient alternative to hospital-based procedures which allows for an improved patient experience, particularly in underserved communities.\u201d<\/p>\n

\nFounded in 2008, AVA develops and manages nearly 20 outpatient vascular centers across the South, Mid-Atlantic, Midwest and Northeastern United States. Partnering with close to 100 interventional cardiologists, radiologists, nephrologists, and vascular surgeons, the company builds purposeful centers to meet the unique needs of each market it serves.<\/p>\n

\n\u201cPetra has been studying the vascular space for several years and has evaluated multiple platforms across the country,\u201d said David Fitzgerald, Partner with Petra Capital. \u201cWhen we met the team at American Vascular and heard their vision for growth and quality, we felt it would make a great partnership. The opportunity to provide better care for patients in lower cost settings fits squarely within Petra\u2019s healthcare investment thesis.\u201d<\/p>\n

\n\u201cWe are thrilled to partner with both the AVA management team and Petra Capital on this investment,\u201d said Scott Long, Managing Partner at Canopy Capital Partners. \u201cIt was clear to us from our initial meeting that this is a differentiated business with a high-quality team and culture.\u201d<\/p>\n

\nAbout American Vascular Associates (AVA)<\/span><\/b><\/p>\n

\nFounded in 2008, AVA has a rich tradition of developing and managing best-in-class outpatient vascular centers with nineteen locations in the South, Mid-Atlantic, Midwest and Northeastern United States. By partnering with close to 100 interventional cardiologists, radiologists, nephrologists, and vascular surgeons we have purpose-built out-patient centers to serve selected markets. For 15 years AVA has been self-funded and is considered one of the nation\u2019s largest providers of outpatient vascular care. Both our mission and our passion are embolic therapies for men and women and amputation prevention. For any inquires please email John Hadden, CDO @ jhadden@americanvascular.com<\/a><\/p>\n

\nAbout Petra Capital Partners<\/span><\/b><\/p>\n

\nPetra Capital Partners is a private equity firm engaged in providing growth capital for companies located throughout the United States. Our investment firm has an established track record of success spanning over 20 years and deploying more than $750 million of capital invested into more than 100 companies. We are seeking investments for our current SBIC fund, Petra Capital Fund IV. We invest in equity or debt securities with a primary focus on backing high growth business services, tech-enabled services and healthcare services companies.<\/p>\n

\nAbout Canopy Capital Partners<\/span><\/b><\/p>\n

\nInvesting since 2015, Canopy Capital Partners (\u201cCCP\u201d) is a private equity investment firm based in Tampa, FL. CCP focuses on partnering with lower middle-market service businesses and management teams throughout Florida and the Southeast. The firm principals have extensive experience in a variety of transactions structures, including recapitalizations, management buyouts, and growth equity investments.<\/p>\n

Contacts<\/b> <\/p>\n

\nJohn Hadden, CDO
\n
jhadden@americanvascular.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TAMPA BAY, Fla.–(BUSINESS WIRE)–Officials with American Vascular Associates, LLC (AVA), a nationally recognized network of outpatient vascular and endovascular centers based in Palm Harbor, Fla., announced today the company\u2019s completion of a growth recapitalization by two leading investment firms, Petra Capital Partners (Nashville, Tenn.) and Canopy Capital Partners (Tampa, Fla.). This transaction will allow for … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56241","6":"format-standard","7":"category-industry"},"yoast_head":"\nAmerican Vascular Associates Announces Growth Recapitalization by Petra Capital and Canopy Capital - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Vascular Associates Announces Growth Recapitalization by Petra Capital and Canopy Capital - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TAMPA BAY, Fla.–(BUSINESS WIRE)–Officials with American Vascular Associates, LLC (AVA), a nationally recognized network of outpatient vascular and endovascular centers based in Palm Harbor, Fla., announced today the company\u2019s completion of a growth recapitalization by two leading investment firms, Petra Capital Partners (Nashville, Tenn.) and Canopy Capital Partners (Tampa, Fla.). This transaction will allow for ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-26T13:04:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230426005234\/en\/1774470\/21\/ava-2019-logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"American Vascular Associates Announces Growth Recapitalization by Petra Capital and Canopy Capital\",\"datePublished\":\"2023-04-26T13:04:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\\\/\"},\"wordCount\":588,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230426005234\\\/en\\\/1774470\\\/21\\\/ava-2019-logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\\\/\",\"name\":\"American Vascular Associates Announces Growth Recapitalization by Petra Capital and Canopy Capital - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230426005234\\\/en\\\/1774470\\\/21\\\/ava-2019-logo.jpg\",\"datePublished\":\"2023-04-26T13:04:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230426005234\\\/en\\\/1774470\\\/21\\\/ava-2019-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230426005234\\\/en\\\/1774470\\\/21\\\/ava-2019-logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Vascular Associates Announces Growth Recapitalization by Petra Capital and Canopy Capital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"American Vascular Associates Announces Growth Recapitalization by Petra Capital and Canopy Capital - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/","og_locale":"en_US","og_type":"article","og_title":"American Vascular Associates Announces Growth Recapitalization by Petra Capital and Canopy Capital - Pharma Trend","og_description":"TAMPA BAY, Fla.–(BUSINESS WIRE)–Officials with American Vascular Associates, LLC (AVA), a nationally recognized network of outpatient vascular and endovascular centers based in Palm Harbor, Fla., announced today the company\u2019s completion of a growth recapitalization by two leading investment firms, Petra Capital Partners (Nashville, Tenn.) and Canopy Capital Partners (Tampa, Fla.). This transaction will allow for ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-26T13:04:34+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230426005234\/en\/1774470\/21\/ava-2019-logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"American Vascular Associates Announces Growth Recapitalization by Petra Capital and Canopy Capital","datePublished":"2023-04-26T13:04:34+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/"},"wordCount":588,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230426005234\/en\/1774470\/21\/ava-2019-logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/","url":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/","name":"American Vascular Associates Announces Growth Recapitalization by Petra Capital and Canopy Capital - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230426005234\/en\/1774470\/21\/ava-2019-logo.jpg","datePublished":"2023-04-26T13:04:34+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230426005234\/en\/1774470\/21\/ava-2019-logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230426005234\/en\/1774470\/21\/ava-2019-logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/american-vascular-associates-announces-growth-recapitalization-by-petra-capital-and-canopy-capital\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"American Vascular Associates Announces Growth Recapitalization by Petra Capital and Canopy Capital"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56241","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56241"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56241\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56241"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56241"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56241"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}